LongCovid_Emblem
Topics
Meeting category
Date(s)
21 Nov 2024 - 22 Nov 2024
Program Language
English
Location
Barcelona, Spain
Meeting type
Hybrid
CME credits
8
Virology Education

Demystifying Long COVID International Conference 2024

Related Enduring Materials

Enduring Materials
Thursday, 21 November
Opening & Welcome - 14:00
14:10 CET
Opening Talk: Long COVID: State of the Science and Directions for Policy and Research
Roger Paredes, MD, PhD
Hospital Germans Trias & IrsiCaixa AIDS Research Institute, Spain
Session 1: Clinical Spectrum - Different Faces of Long COVID -
14:40 CET
Epidemiology and Long Term Evolution of Long COVID
Olivier Robineau, MD, PhD
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, France
15:05 CET
Autonomic Dysfunction in long COVID
Nicola Montano, PhD
University of Milan, Italy
15:30 CET
Long COVID in Children
Danilo Buonsenso, MD, PhD
Gemelli University Hospital, Italy
Session 2: Abstract-Driven Session -
16:30 CET
#1 - Clinical Insights From a Pediatric Long COVID Clinic
Sindhu Mohanadas
United States
16:42 CET
#2 - Impact of Persistent Symptoms on Quality of Life in Long COVID Patients: A Comparative Study
David Lerma Irureta
Spain
16:55 CET
#3 - Long COVID and Associated Outcomes Following COVID-19 Reinfections: Insights from an International Patient-Led Survey
Gina Assaf & Leticia Soares
United States
17:07 CET
#4 - An Innovative Digital Health Solution to Address Unmet Needs in Long COVID: Results From the Co-design Study of the Long COVID Companion App
Aurélie Fischer & Pauline Oustric
France
Session 3: Patient-Centred Coordination of Care - Where Do We Stand? -
17:20 CET
Dutch Example
Mischa Huson, MD, PhD, DTM&H
Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands
17:30 CET
Spanish Example
Lourdes Mateu, MD, PhD
Germans Trias i Pujol Hospital, Spain
17:40 CET
French Example
Jérôme Larché, MD, MSc
Clinique du Parc, France
Friday, 22 November
Session 4: Pathophysiology -
08:30 CET
Immune Dysregulation and Autoimmunity in Long COVID
Daniel M. Altmann, PhD
Imperial College London, United Kingdom
08:55 CET
Viral Reservoirs and Consequences of SARS-CoV-2 Persistence
Morgane Bomsel, PhD
Institut Cochin, Paris, France
09:20 CET
#5 - Persistent Immune Dysregulation and Metabolic Alterations Following SARS-CoV-2 Infection
Irini Sereti
United States
09:32 CET
#6 - Unraveling the Molecular Signature of Long COVID with Post-Exertional Fatigue: An Analysis of Circulating Proteomic and Metabolomic Profiles
Marta Massanella
Spain
09:44 CET
#7 - Sub-maximal 2-day Cardiopulmonary Exercise Testing to Assess Exercise Tolerance and Symptom Responses in People with Long COVID
Callum Thomas
United Kingdom
Session 5: Diagnostics, Biomarkers, and End Points -
10:20 CET
Molecular PET imaging of long COVID
Eric Guedj, MD, Dipl.-Ing, PhD
Aix-Marseille University / Timone Hospital / Fresnel Institute, France
10:45 CET
Tomorrow, and Tomorrow, and Tomorrow... Studies of the Neuropathogenesis of Long COVID
Serena Spudich, MD
Yale University, United States
11:10 CET
#8 - Normalization of Cognitive Function in Patients With Neurological Symptoms Post COVID-19 After 12 Months
Siv Elin Pignatiello
Norway
11:22 CET
#9 - Plasma Biomarkers in Children and Young People With Long COVID
Jon Izquierdo-Pujol
Spain
Session 6: Illustrating the Challenges - Clinical Case Presentations -
13:35 CET
Case 1: Differential Diagnosis
Gemma Lladós, MD
Hospital Germans Trias i Pujol, Spain
14:00 CET
Case 2: No Cure, What Are the Options
Clara Lehmann, MD
University of Cologne, Germany
Session 7: Clinical Trials - Prevention and Treatment Options on the Horizon -
14:55 CET
Long Covid Therapeutic Trials: Current Status
Dominique Salmon, MD, PhD
Institut Fournier, France
15:20 CET
What Have We Learned from Observational Studies to Improve Future Clinical Trials
Igho Ofotokun, MD, MSc, FIDSA
Emory University, United States
15:45 CET
Viral Persistence and Long COVID: Lessons Learned from the First Round of Clinical Trials
Michael Peluso, MD
University of California, San Francisco, United States
16:10 CET
#10 - Anticoagulant and Antiviral Therapy in Long COVID: A Real-World Prospective Cohort Study and Grassroots Patient-Designed Trial
Johan Van Weyenbergh
Belgium
16:22 CET
#11 - Exploring the Efficacy of Plasma Exchange Therapy in Post-COVID-19 Condition: A Pilot Randomized Double-Blind Trial
Sergio España Cueto
Spain
16:35 CET
Patient Perspective on Clinical Trials Design
Chantal Britt, MA
Long Covid Switzerland, Switzerland

End of the Program

Overview
Thank you!

We are pleased to reflect on the highly successful conference for the Demystifying Long COVID International Conference 2024. 

The Program Chair and organizers would like to thank the speakers, chairs, and all participants for their contribution to this meeting!

Special thanks to the conference supports. Without their contribution, this conference would not have been made possible.

Registration to follow full session online is still possible. We are delighted to provide the following registration options (to receive these, please reach out to Karen.Lam@amededu.com): 

•    €75 fee for students,
•    25% discount for attendees from the previous year,
•    €200 fee for regular delegates from Spain.


To stay updated on the latest developments, make sure you are signed up for our newsletter

About this Program

The Demystifying Long COVID International Conference 2024 took place on 21 - 22 November 2024 in Barcelona, Spain. This conference aimed to raise awareness, clarify misconceptions, promote understanding, and stimulate discussion amongst healthcare professionals, investigators, policymakers, and community representatives on the clinical manifestations, management, plausible preventive and therapeutic options, and public health challenges related to Long COVID (or post-acute sequelae of COVID-19).

Knowledge of symptom-specific testing and diagnostic recommendations for Long COVID is still limited. The possible protective role of vaccination remains an extensive area of research, likewise the possible effect of antiviral and other treatment strategies. This highlights the importance of sustained medical education and regular updates on guidelines.

The program has featured state-of-the-art lectures, case presentations, and interactive sessions tailored to address educational needs in global healthcare settings. Ample time was reserved for debates and panel discussions to enhance knowledge exchange and reinforce the implementation of clinical guidelines and recommendations.

This has been done in the unique context of the COVID-19 pandemic considering regional differences in epidemiology, morbidity and mortality, access to vaccines, tests, and medications, health system capacity, and public health measures.

Program Chairs
General Information 
Who Should Attend?
- Pulmonologists
- Neurologists
- Internal Medicine Physicians
- Infectious Diseases Physicians
- Family Doctors
- Cardiologists
- Psychiatrists
- Occupational Therapists
- Clinical/Translational investigators
- Policymakers
Meeting Objectives
This meeting aimed to:
- Raising awareness and educating HCPs
- Facilitating translation of new findings into daily practice
- Stimulating clinical research and data sharing
Learning Objectives
After participating in this activity, participants will be able to:
- Define the Long COVID syndrome, and describe diagnostic challenges
- Understand epidemiology and trends in the prevalence in relation to the severity of acute COVID, the vaccination status, age, etc.
- Describe the multisystem pathologies of Long COVID
- Improve management of people living with Long COVID
- Summarize clinical data on potential preventive and treatment options
Practical Information 

We trust that the following information will assist you in organizing your participation for the Demystifying Long COVID International Conference 2024.

Venue
The conference will be held at the Alexandre Hotel Fira Congress.

Full address: Polígono Industrial de la Pedrosa, C. de José Agustín Goytisolo, 9, 11, 08908 L'Hospitalet de Llobregat, Barcelona, Spain

Accommodation is not included in the registration rate.
Travel & Accommodation
The registration for this conference does not include travel & accommodation. If you require a visa to enter Spain to attend this conference face-to-face, a visa letter will be issued after completing the registration page.
Badges
All participants are requested to wear the badge at all times during the conference to ensure admission to the meeting.
Certificate of Attendance
A certificate of attendance will be sent to you after successfully completing the program and post-meeting survey.
Language
The official language of the conference is English.
Translation will not be provided.
Conference Materials
Conference materials can be obtained upon registration at the registration desk at the Conference Venue.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the conference is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.

Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Committees
Chairs 2024
Organizing Committee

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the conference, identify interesting topics and candidate speakers, and review all submitted abstracts.

Scientific Program Coordinator
Scientific Committee

The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, they participate in reviewing submitted abstracts, and play an active role during the conference as moderators and/or chairs of sessions. 

  • Daniel Altmann, PhD, Imperial College London, United Kingdom
  • Tomaso Antonacci - Long Covid Belgium, Belgium
  • Danilo Buonsenso, MD, PhD - Woman and Child Health and Public Health Rome, Italy
  • Giovanni Guaraldi, MD - University of Modena and Reggio Emilia, Italy
  • Marc Jamoulle, MD, PhD, University of Liège, Belgium
  • Clara Lehmann, MD, German Center For Infectious Research / University Hospital Cologne, Germany
  • Pauline Oustric, PhD - #ApresJ20 Association Covid Long France, INSERM/Centre Léon Bérard, France
Support
Platinum Level
Supporter Level (Founding Sponsor)
Networking Reception Sponsor
Friend Level
Support Our Initiative

Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and researchers interested in the Demystifying Long COVID International Conference 2024.
 
This collaboration plays a vital role in both the organizational as well as scientific success of the program.To show your commitment to the cause, get in touch with us for a tailored
support package by contacting Ms. Daria Bohdanova at daria.bohdanova@amededu.com

Benefits of Support

By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

  • Symposium opportunities
  • Non-commercial interviews with company representatives
  • Verbal acknowledgement during the program 
  • Discounted and complimentary registrations for your representatives
  • Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
  • Company acknowledgement on printed meeting materials including but not limited to banners and the program book
  • Digital and printed advertising opportunities 
  • Social media shout-outs
  • Logo on the conference bag 

 
*Subject to the support level.

Symposium
Antivirals for the Prevention of Long COVID What Do Real-World Data Show?

This satellite symposium was presented by:

Pfizer

Program | 22 November 2024 - 12:00
12:00 CET
Opening
12:02 CET
Antivirals for Prevention of Long COVID: Overview of Real-World Data
Igho Ofotokun, MD, MSc, FIDSA
Emory University, United States
12:17 CET
DEBATE: Antivirals Can Prevent Long COVID
12:19 CET
Voting
12:21 CET
PRO Standpoint
Dominique Salmon, MD, PhD
Institut Fournier, France
12:28 CET
CON Standpoint
Roger Paredes, MD, PhD
Hospital Germans Trias & IrsiCaixa AIDS Research Institute, Spain
12:36 CET
Discussion with the Audience
12:51 CET
Rebuttal
12:53 CET
Voting
12:55 CET
Results & Closing
Previous Editions
Endorsers
Accreditation
EACCME® Accreditation
CME.png

The Demystifying Long COVID International Conference 2024, Barcelona, Spain 21/11/2024 - 22/11/2024, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 8.5 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.


Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.


Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

How can I receive a CME-accredited Certificate of Attendance?

In order to be eligible to receive a CME-accredited Certificate of Attendance, you must have followed the full program and completed the post-evaluation survey. Please check your junk/spam inbox if you cannot find the email containing your link to the survey. If you followed the program and did not receive an email with a link to the survey, please email us at Karen.Lam@amededu.com.

​The post-evaluation survey will be online for 1 week after the conference. Please complete the survey within this time in order to receive your CME-accredited Certificate of Attendance. Once the survey is closed, it cannot be reopened.

Please note that CME accreditation is only provided for delegates who attend the event livestream and submit the post-meeting survey.

Language
Ratings previous edition
The activity was well-planned
4.9
(126)
Content is relevant to my practice
4.7
(126)
Content was presented clearly
4.8
(126)
Content was free from commercial bias
4.3
(126)